{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T17:10:11Z","timestamp":1762535411375,"version":"build-2065373602"},"reference-count":58,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","oooojournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.oooo.2025.08.007","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T03:13:55Z","timestamp":1755746035000},"page":"748-758","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Distinct expression profiles of hsa-miR-31, hsa-miR-29c, hsa-miR-17, and hsa-miR-10a in oral epithelial dysplasia and squamous cell carcinoma"],"prefix":"10.1016","volume":"140","author":[{"given":"Ana Paula Negreiros Nunes","family":"Alves","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina Rodrigues","family":"Te\u00f3filo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario Rogerio Lima","family":"Mota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabricio Bitu","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camile de Barros","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c2ndrea Kely Campos","family":"Ribeiro dos Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe Pantoja","family":"Mesquisa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1513-9027","authenticated-orcid":false,"given":"Paulo Goberl\u00e2nio Barros","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel Carvalho","family":"Montenegro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.oooo.2025.08.007_bib0001","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.oooo.2025.08.007_bib0002","first-page":"1","article-title":"The role of microRNAs in oral carcinogenesis","volume":"23","author":"Gulyaeva","year":"2016","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.oooo.2025.08.007_bib0003","first-page":"R17","article-title":"MicroRNAs: tiny regulators with great impact on gene expression","volume":"23","author":"Schmitz","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.oooo.2025.08.007_bib0004","first-page":"909","article-title":"MicroRNAs: an overview of their role in regulating gene expression","volume":"118","author":"Davide","year":"2017","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.oooo.2025.08.007_bib0005","first-page":"471","article-title":"MicroRNA expression profiling and its clinical significance in human hepatocellular carcinoma","volume":"50","author":"Liu","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.oooo.2025.08.007_bib0006","first-page":"4","article-title":"MicroRNAs and the cancer hallmarks: a review","volume":"45","author":"Dragomir","year":"2018","journal-title":"Clin Mol Pathol"},{"key":"10.1016\/j.oooo.2025.08.007_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.archoralbio.2023.105627","article-title":"MiRNAs as non-invasive biomarkers in the serum of oral squamous cell carcinoma (OSCC) and oral potentially malignant disorder (OPMD) patients","volume":"147","author":"Mazumder","year":"2023","journal-title":"Arch Oral Biol"},{"key":"10.1016\/j.oooo.2025.08.007_bib0008","doi-asserted-by":"crossref","first-page":"7298","DOI":"10.1038\/s41598-021-86316-w","article-title":"MiRNA expression profiling and emergence of new prognostic signature for oral squamous cell carcinoma","volume":"11","author":"Rajan","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.oooo.2025.08.007_bib0009","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3892\/or.2020.7854","article-title":"Diagnostic and therapeutic role of microRNAs in oral cancer","volume":"45","author":"Wang","year":"2020","journal-title":"Oncol Rep"},{"key":"10.1016\/j.oooo.2025.08.007_bib0010","first-page":"134","article-title":"Field cancerization: a key concept for the understanding of cancer progression","volume":"7","author":"Gabusi","year":"2017","journal-title":"Front Oncol"},{"key":"10.1016\/j.oooo.2025.08.007_bib0011","first-page":"244","article-title":"Field cancerization in oral cancer","volume":"10","author":"Mohan","year":"2014","journal-title":"J Cancer Res Ther"},{"key":"10.1016\/j.oooo.2025.08.007_bib0012","first-page":"155","article-title":"MicroRNA expression profiling in formalin-fixed paraffin-embedded tissue: a technique for investigating microRNA expression in archival material","volume":"13","author":"Gee","year":"2011","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.oooo.2025.08.007_bib0013","first-page":"3529","article-title":"STAT3: an oncogene and target for cancer therapy","volume":"76","author":"Geiger","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.oooo.2025.08.007_bib0014","first-page":"738","article-title":"IL-6: a potential therapeutic target in head and neck squamous cell carcinoma","volume":"51","author":"Johnston","year":"2015","journal-title":"Oral Oncol"},{"key":"10.1016\/j.oooo.2025.08.007_bib0015","first-page":"4305","article-title":"Tocilizumab inhibits STAT3 phosphorylation and vascular endothelial growth factor production by human oral squamous cell carcinoma cell lines","volume":"15","author":"Shinriki","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.oooo.2025.08.007_bib0016","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.gendis.2021.10.009","article-title":"MicroRNAs and JAK\/STAT3 signaling: a new promising therapeutic axis in blood cancers","volume":"9","author":"Sajjadi-Dokht","year":"2021","journal-title":"Genes Dis"},{"key":"10.1016\/j.oooo.2025.08.007_bib0017","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1590\/S0034-89102010000300021","article-title":"STROBE initiative: guidelines on reporting observational studies","volume":"44","author":"Malta","year":"2010","journal-title":"Rev Saude Publica"},{"key":"10.1016\/j.oooo.2025.08.007_bib0018","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.oraloncology.2013.03.430","article-title":"MicroRNA-17\/20a functions to inhibit cell migration and can be used a prognostic marker in oral squamous cell carcinoma","volume":"49","author":"Chang","year":"2013","journal-title":"Oral Oncol"},{"year":"2005","series-title":"World Health Organization Classification of Tumours: Pathology & Genetics of Head and Neck Tumours","author":"Barnes","key":"10.1016\/j.oooo.2025.08.007_bib0019"},{"key":"10.1016\/j.oooo.2025.08.007_bib0020","doi-asserted-by":"crossref","first-page":"e2314","DOI":"10.1097\/MD.0000000000002314","article-title":"Influence of educational level, stage, and histological type on survival of oral cancer in a Brazilian population: a retrospective study of 10 years observation","volume":"95","author":"Dantas","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.oooo.2025.08.007_bib0021","doi-asserted-by":"crossref","first-page":"45","DOI":"10.5009\/gnl.2012.6.1.45","article-title":"The immunohistochemical expression of STAT3, bcl-xL, and MMP-2 proteins in colon adenoma and adenocarcinoma","volume":"6","author":"Lee","year":"2012","journal-title":"Gut Liver"},{"key":"10.1016\/j.oooo.2025.08.007_bib0022","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.transproceed.2009.12.060","article-title":"C4D immunostaining in surveillance endomyocardial biopsies from well-functioning heart allografts","volume":"42","author":"Arias","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1016\/j.oooo.2025.08.007_bib0023","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.oooo.2025.08.007_bib0024","first-page":"115","article-title":"miR-31 as a potential therapeutic target in oral cancer: a comprehensive review","volume":"6","author":"De Sarkar","year":"2014","journal-title":"Int J Oral Sci"},{"key":"10.1016\/j.oooo.2025.08.007_bib0025","first-page":"5175","article-title":"Altered expression of microRNA profiles in perilesional oral mucosa of patients with oral squamous cell carcinoma and their potential clinical relevance","volume":"36","author":"Hudcova","year":"2016","journal-title":"Anticancer Res"},{"key":"10.1016\/j.oooo.2025.08.007_bib0026","first-page":"5437","article-title":"Expression profile and clinical significance of microRNA-21, -125b and -145 in patients with oral squamous cell carcinoma: a case\u2013control study","volume":"15","author":"Lopes","year":"2018","journal-title":"Oncol Lett"},{"key":"10.1016\/j.oooo.2025.08.007_bib0027","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1073\/pnas.0510565103","article-title":"A microRNA expression signature of human solid tumors defines cancer subtypes and predicts clinical outcome","volume":"103","author":"Volinia","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.oooo.2025.08.007_bib0028","first-page":"153","article-title":"Field cancerization and its impact on the diagnosis and treatment of oral squamous cell carcinoma","volume":"25","author":"Katarzyna","year":"2016","journal-title":"Adv Clin Exp Med"},{"key":"10.1016\/j.oooo.2025.08.007_bib0029","first-page":"784","article-title":"Field cancerization in the head and neck: a review of the current concepts","volume":"34","author":"Mane","year":"2012","journal-title":"Head Neck"},{"key":"10.1016\/j.oooo.2025.08.007_bib0030","first-page":"494","article-title":"Overexpression of microRNA-31 is associated with tumorigenesis and invasion in oral squamous cell carcinoma","volume":"214","author":"Wong","year":"2008","journal-title":"J Pathol"},{"issue":"3","key":"10.1016\/j.oooo.2025.08.007_bib0031","first-page":"1371","article-title":"MicroRNA-17 promotes proliferation and invasion of oral squamous cell carcinoma cells by targeting RUNX3","volume":"34","author":"Shi","year":"2015","journal-title":"Oncol Rep"},{"key":"10.1016\/j.oooo.2025.08.007_bib0032","first-page":"267","article-title":"MicroRNA profiling of serum from head and neck cancer patients identifies potential biomarkers","volume":"10","author":"Maclellan","year":"2012","journal-title":"Cancer Biomark"},{"key":"10.1016\/j.oooo.2025.08.007_bib0033","first-page":"6217","article-title":"MicroRNA-17 promotes oral squamous cell carcinoma cell proliferation through targeting p21WAF1\/CIP1 and inhibiting apoptosis","volume":"34","author":"Wu","year":"2013","journal-title":"Tumour Biol"},{"key":"10.1016\/j.oooo.2025.08.007_bib0034","first-page":"1607","article-title":"MicroRNA-17 promotes proliferation of tongue squamous cell carcinoma by inhibiting RUNX3 expression and inducing cell cycle progression","volume":"36","author":"Wu","year":"2016","journal-title":"Oncol Rep"},{"key":"10.1016\/j.oooo.2025.08.007_bib0035","first-page":"1","article-title":"MicroRNA-17 promotes migration and invasion of human oral squamous cell carcinoma cells by targeting RUNX3","volume":"20","author":"Song","year":"2020","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.oooo.2025.08.007_bib0036","first-page":"78","article-title":"MicroRNA-17 inhibits cell migration and invasion of oral squamous cell carcinoma by targeting ITG\u03b28","volume":"230","author":"Chang","year":"2013","journal-title":"J Pathol"},{"key":"10.1016\/j.oooo.2025.08.007_bib0037","doi-asserted-by":"crossref","first-page":"e259","DOI":"10.1111\/ajco.12979","article-title":"Downregulated miR-17, miR-29c, miR-92a and miR-214 may be related to BCL11B overexpression in T cell acute lymphoblastic leukemia","volume":"14","author":"He","year":"2018","journal-title":"Asia Pac J Clin Oncol"},{"key":"10.1016\/j.oooo.2025.08.007_bib0038","first-page":"5441","article-title":"miRNA-10a promotes cancer cell proliferation in oral squamous cell carcinoma by upregulating GLUT1 and promoting glucose metabolism","volume":"17","author":"Chen","year":"2019","journal-title":"Oncol Lett"},{"key":"10.1016\/j.oooo.2025.08.007_bib0039","first-page":"689","article-title":"Expression profiling of microRNAs in buccal squamous cell carcinoma and its potential as biomarkers","volume":"15","author":"Siow","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.oooo.2025.08.007_bib0040","first-page":"1","article-title":"Correlation between microRNA-31 expression and clinicopathological features in oral squamous cell carcinoma","volume":"7","author":"Severino","year":"2015","journal-title":"Head Neck Oncol"},{"key":"10.1016\/j.oooo.2025.08.007_bib0041","first-page":"1","article-title":"MicroRNAs and their role in oral cancer: an update","volume":"8","author":"Chattopadhyay","year":"2016","journal-title":"Int J Oral Sci"},{"key":"10.1016\/j.oooo.2025.08.007_bib0042","first-page":"76704","article-title":"MicroRNA-31 is a potential diagnostic and prognostic biomarker for oral squamous cell carcinoma","volume":"7","author":"Hung","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.oooo.2025.08.007_bib0043","first-page":"1098","article-title":"MicroRNA-31 is up-regulated in saliva and plasma of oral squamous cell carcinoma patients and is associated with tumor stage","volume":"48","author":"Li","year":"2012","journal-title":"Oral Oncol"},{"key":"10.1016\/j.oooo.2025.08.007_bib0044","first-page":"1","article-title":"MicroRNA-31 targets RUNX3 to promote oral squamous cell carcinoma cell proliferation and metastasis","volume":"12","author":"Xiao","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.oooo.2025.08.007_bib0045","first-page":"2157","article-title":"MicroRNA-31 promotes migration and invasion of tongue squamous cell carcinoma cells by targeting RUNX3","volume":"9","author":"Maimaiti","year":"2015","journal-title":"Oncol Lett"},{"key":"10.1016\/j.oooo.2025.08.007_bib0046","first-page":"906","article-title":"MicroRNA-31 plays an oncogenic role in the development of oral squamous cell carcinoma","volume":"46","author":"Liu","year":"2010","journal-title":"Oral Oncol"},{"key":"10.1016\/j.oooo.2025.08.007_bib0047","first-page":"76704","article-title":"MicroRNA-31 is a potential diagnostic and prognostic biomarker for oral squamous cell carcinoma","volume":"7","author":"Hung","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.oooo.2025.08.007_bib0048","first-page":"41","article-title":"MicroRNA-31 promotes migration and invasion of oral squamous cell carcinoma cells by targeting CXCL12","volume":"55","author":"Kao","year":"2019","journal-title":"Int J Oncol"},{"key":"10.1016\/j.oooo.2025.08.007_bib0049","first-page":"2205","article-title":"MicroRNA-29b, a novel therapeutic target for oral squamous cell carcinoma","volume":"68","author":"Sengupta","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.oooo.2025.08.007_bib0050","first-page":"1757","article-title":"microRNA-29b suppresses the proliferation of human tongue squamous cell carcinoma cells by targeting STAT3","volume":"9","author":"Guan","year":"2015","journal-title":"Oncol Lett"},{"key":"10.1016\/j.oooo.2025.08.007_bib0051","first-page":"3389","article-title":"MicroRNA-29b inhibits the proliferation of human tongue squamous cell carcinoma cells by targeting AKT","volume":"12","author":"Hu","year":"2015","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.oooo.2025.08.007_bib0052","first-page":"1465","article-title":"MicroRNA-29b inhibits tumor growth and metastasis of human oral squamous cell carcinoma by targeting AKT","volume":"37","author":"Liu","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1016\/j.oooo.2025.08.007_bib0053","first-page":"3475","article-title":"MicroRNA-29b suppresses proliferation and invasion of human oral squamous cell carcinoma cells by targeting DNMT3A","volume":"36","author":"Matsushima","year":"2016","journal-title":"Oncol Rep"},{"key":"10.1016\/j.oooo.2025.08.007_bib0054","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.21037\/atm-21-3720","article-title":"MiR-29c inhibits the metastasis of oral squamous cell carcinoma and promotes its cell cycle arrest by targeting SERPINH1","volume":"9","author":"Wang","year":"2021","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.oooo.2025.08.007_bib0055","first-page":"1","article-title":"MiR-29c-3p and MiR-223-3p regulate the proliferation and drug resistance of oral squamous cell carcinoma by targeting ANGPTL4","volume":"4","author":"Bian","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.oooo.2025.08.007_bib0056","first-page":"4579","article-title":"MicroRNA-29c inhibits proliferation and invasion of human oral squamous cell carcinoma cells by targeting PTEN","volume":"37","author":"Peng","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1016\/j.oooo.2025.08.007_bib0057","first-page":"9","article-title":"MicroRNA-29c inhibits the proliferation and invasion of human tongue squamous cell carcinoma cells by targeting PTEN","volume":"8","author":"Xue","year":"2013","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.oooo.2025.08.007_bib0058","first-page":"685","article-title":"MicroRNA-29c inhibits proliferation and invasion of human tongue squamous cell carcinoma cells by targeting PTEN","volume":"6","author":"Sun","year":"2012","journal-title":"Mol Med Rep"}],"container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212440325011678?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212440325011678?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T17:06:37Z","timestamp":1762535197000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212440325011678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2212440325011678"],"URL":"https:\/\/doi.org\/10.1016\/j.oooo.2025.08.007","relation":{},"ISSN":["2212-4403"],"issn-type":[{"type":"print","value":"2212-4403"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distinct expression profiles of hsa-miR-31, hsa-miR-29c, hsa-miR-17, and hsa-miR-10a in oral epithelial dysplasia and squamous cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oooo.2025.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}